Companies /Technology

Cognex Corp

NASDAQ: CGNX Scientific & Technical Instruments
$62.97
â–² $1.25 (+2.03%) today
Markets closed · 7:43pm ET

Q2 2025 Earnings

Reported Jul 30, 2025, 4:34pm ET · SEC source
$0.24
Beat +4.35%
EPS · est. $0.23
$249.1M
Beat +1.21%
Revenue · est. $246.1M
+28.5%
Beating market
CGNX vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−7%0+7%+14%Jul 30Jul 31report 4:34pm ETearnings−0.9%+11.4%
−7%0+7%+14%Jul 30Jul 31earnings−0.9%+11.4%
CGNX +11.4%S&P 500 −0.9%
−7%0+7%+14%Jul 30Jul 31report 4:34pm ETearnings−1.5%+11.4%
−7%0+7%+14%Jul 30Jul 31earnings−1.5%+11.4%
CGNX +11.4%NASDAQ −1.5%
−7%0+7%+14%Jul 29Aug 7report 4:34pm ETearnings−0.8%+11.8%
−7%0+7%+14%Jul 29Aug 7earnings−0.8%+11.8%
CGNX +11.8%S&P 500 −0.8%
−7%0+7%+14%Jul 29Aug 7report 4:34pm ETearnings−0.5%+11.8%
−7%0+7%+14%Jul 29Aug 7earnings−0.5%+11.8%
CGNX +11.8%NASDAQ −0.5%
−1.46%
Day of report
+20.76%
Next session
+21.12%
One week
+30.15%
30 days

S&P 500 over the same 30 days: +1.67%.

Did CGNX Beat Earnings? Q2 2025 Results

Cognex delivered a clean beat to open the second half of 2025, with Q2 revenue of $249.09 million edging past the $246.11 million consensus by 1.21% and rising 4.1% year over year, while adjusted EPS of $0.24 topped the $0.24 estimate by 1.57%. The headline numbers were underpinned by a profitability milestone that caught investor attention: adjusted EBITDA margin crossed above 20% for the first time since Q2 2023, reaching 20.7%, as disciplined cost management drove operating expenses down 3% year over year and more than offset a 230 basis point compression in adjusted gross margin tied to less favorable industry mix and modest tariff headwinds. Free cash flow surged 74% to $40.43 million, and the company ended the quarter debt-free with $553.00 million in cash and investments. The strong results helped propel the stock to a new 52-week high. Looking ahead, management guided Q3 revenue of $245 to $265 million, representing approximately 9% year-over-year growth at the midpoint, with adjusted EPS of $0.24 to $0.29 implying 35% growth.

Key Takeaways
  • Revenue growth driven by strength in Logistics and broader Factory Automation
  • Consumer Electronics and Packaging drove Factory Automation growth
  • Operating expenses declined 3% year over year through disciplined cost management
  • Salesforce transformation delivering impactful results, expanding reach in Packaging customers
  • Free cash flow conversion rate of 100% of net income in Q2

“We're focused on executing on our strategic priorities and delivering on our long-term financial framework to drive shareholder value. The second quarter represents an early, but meaningful, step forward in this journey, marked by continued Adjusted EBITDA margin expansion and strong free cash flow generation — both of which we believe are important indicators of our financial discipline and long-term value creation.”

Cognex CEO, on the earnings call

Forward Guidance & Outlook

For Q3 2025, Cognex guided revenue of $245 million to $265 million (excluding a one-time commercial partnership benefit of $8-$14 million), representing approximately 9% year-over-year growth at the midpoint. Adjusted EBITDA margin is expected at 19.5% to 22.5%, up significantly from 17.6% in Q3 2024. Adjusted EPS (diluted) is guided at $0.24 to $0.29, implying 35% year-over-year growth at the midpoint. The company continues to expect no material impact on Adjusted EPS or Adjusted EBITDA margin from tariffs, including recently announced trade agreements with China, Vietnam, and Indonesia. Cognex expects the One Big Beautiful Bill Act (OBBBA) to be neutral to Adjusted EPS in 2025 with a cash tax benefit of $12-$15 million expected in 2025.

CGNX YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$70.0M$140.0M$210.0M$239.3M$249.1MRevenue$166.6M$167.9MGross Profit$38.5M$43.4MOperating Income$36.2M$40.5MNet Income
$0$70.0M$140.0M$210.0MRevenueGross ProfitOperating IncomeNet Income

Figures from SEC filings and company reports. Not investment advice.